Table 1. Essential medicines for cancer on the national essential medicines lists or national reimbursable medicines lists of 135 countries, 2015.
Medicine | No. of countries listing medicine (%) |
---|---|
On WHO 2013 Model List | |
Asparaginase | 68 (50) |
Bleomycin | 94 (70) |
Calcium folinate | 84 (62) |
Carboplatin | 73 (54) |
Chlorambucil | 84 (62) |
Cyclophosphamide | 120 (89) |
Cytarabine | 88 (65) |
Dacarbazine | 73 (54) |
Dactinomycin | 67 (50) |
Daunorubicin | 55 (41) |
Docetaxel | 56 (42) |
Doxorubicin | 99 (73) |
Etoposide | 84 (62) |
Fluorouracil | 109 (81) |
Hydroxycarbamide | 88 (65) |
Ifosfamide | 60 (44) |
Mercaptopurine | 87 (64) |
Mesna | 53 (39) |
Methotrexate | 128 (95) |
Paclitaxel | 65 (48) |
Procarbazine | 62 (46) |
Tamoxifen | 112 (83) |
Tioguanine | 36 (27) |
Vinblastine | 83 (61) |
Vincristine | 111 (82) |
Added to WHO Model List via 2015 revision | |
All-trans retinoic acida | 19 (14) |
Aromatase inhibitorsb | 50 (37) |
Bendamustine | 1 (0.7) |
Bicalutamide | 38 (28) |
Capecitabine | 49 (36) |
Cisplatin | 97 (72) |
Fludarabine | 40 (30) |
Gemcitabine | 46 (34) |
Granulocyte colony stimulating factorsc | 63 (47) |
Imatinib | 40 (30) |
Irinotecan | 41 (30) |
Leuprolin classd | 53 (39) |
Oxaliplatin | 49 (36) |
Rituximab | 34 (25) |
Trastuzumab | 26 (19) |
Vinorelbine | 37 (27) |
Other medicinese | |
Arsenic trioxide | 2 (1) |
Dasatinib | 10 (7) |
Diethylstilboestrol | 6 (4) |
Erlotinib | 14 (10) |
Gefitinib | 9 (7) |
Nilotinib | 12 (9) |
WHO: World Health Organization.
a In capsule or tablet form only. Also known as tretinoin.
b Anastrazole, exemestane and/or letrozole.
c Filgrastim, lenograstim and/or pegfilgrastim.
d Goserelin, leuprolin and/or triptorelin.
e Proposed for inclusion in the 2015 WHO Model List but excluded by the relevant expert committee.